Gerresheimer AG’s Annual General Meeting Affirms Commitment to Growth Strategy

by APAZONE
0 comment 2 minutes read

Annual General Meeting Backs Gerresheimer AG’s Growth Course

The Annual General Meeting of Gerresheimer AG expresses confidence in the Management Board and Supervisory Board, recording high approval rates for all agenda items.

Dividend of EUR 1.25 and Flexible Financing for Further Growth

The company pays a dividend of EUR 1.25 per share for the strong financial year 2022 and gains approval for the creation of new authorized and conditional capital, enhancing flexibility in financing future growth.

Reaffirming Forecast of Double-Digit Growth

CEO Dietmar Siemssen reaffirms the company’s forecast, expecting double-digit growth in revenues and earnings, emphasizing the company’s position as a profitable growth company and strategic partner in the pharma and biotech industries.

Strong Performance and High Approval Rates

Gerresheimer achieves a strong performance in the challenging economic environment, generating revenues of EUR 1.82 billion and adjusted EBITDA of EUR 354 million in 2022. The Annual General Meeting approves all resolutions with a large majority, endorsing the actions of the Management Board and Supervisory Board.

Dividend Payment and Auditing for 2023

The approved dividend of EUR 1.25 per share will be paid out on June 12, 2023. Deloitte GmbH Wirtschaftsprüfungsgesellschaft is elected as the auditor for the financial year 2023.

The detailed voting results for the items on the Annual General Meeting’s agenda are available here.

The speech by the Chief Executive Officer at the Annual General Meeting is available here.

The Annual Report is available here.

Source: Gerresheimer AG with additional information added by GlassBalkan

You may also like

Leave a Comment

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Accept All Cookies Cookies Policy